Public Profile

Bioiks

Bioiks, officially known as Bioiks d.o.o., is a prominent player in the biotechnology sector, headquartered in Slovenia (SI). Founded in 2015, the company has rapidly established itself in the fields of biopharmaceuticals and innovative healthcare solutions, focusing on the development of cutting-edge products that enhance patient outcomes. With a commitment to research and development, Bioiks offers a range of unique biotechnological services and products, including advanced therapeutics and diagnostic tools. Their emphasis on quality and innovation has positioned them as a leader in the industry, earning recognition for their contributions to healthcare advancements. Operating primarily in Slovenia and expanding into broader European markets, Bioiks continues to achieve significant milestones, reflecting its dedication to improving health through science.

DitchCarbon Score

How does Bioiks's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

14

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Bioiks's score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Bioiks's reported carbon emissions

Bioiks, headquartered in SI, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, there are no documented reduction targets or climate pledges that outline their commitment to reducing carbon emissions. In the absence of specific data, it is essential to note that many companies in the industry are increasingly focusing on sustainability and climate action. Bioiks may be expected to align with these trends, potentially exploring initiatives aimed at reducing their carbon footprint in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bioiks's primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Bioiks is headquartered in SI, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Bioiks is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

SBTi
CDP
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in

Medxl

NL
Medical Device Manufacturing
Updated about 21 hours ago

Medpak

JO
Medical Device Manufacturing
Updated 11 days ago
CDP

Swedish Orphan Biovitrum

SE
Medical Device Manufacturing
Updated about 9 hours ago

Msn Laboratories

IN
Medical Device Manufacturing
Updated 9 days ago

Simcere Pharmaceutical

CN
Medical Device Manufacturing
Updated 7 days ago

Natsume Optical Co., Ltd.

JP
Medical Device Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers